Delivery Order SPE2DX22D0019-SPE2D826FCF74
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,204.76 firm fixed-price delivery order to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a non-set-aside, competitively awarded contract with performance occurring in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor and healthcare solutions...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $982,801.07 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract utilizes firm fixed pricing and was not issued under a set-aside program, indicating competitive award based on open competition. This delivery order represents work performed under AmerSourceBergen's...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,849.64 by the Defense Department's Medical Supply Chain division. This firm fixed-price contract, issued on June 26, 2025, with an ultimate completion date of June 27, 2025, represents a competitive award with no set-aside designation. The delivery order is a child contract under AmerSourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Department of Defense Medical Supply Chain awarded a $44,491.20 firm fixed-price delivery order to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 6, 2026, with completion targeted for January 7, 2026. This non-competitive delivery order was issued under AmerSourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999.9 million through December 2026. The contract utilizes this comprehensive...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $16,684.20 by the Defense Logistics Agency's Medical Supply Chain on December 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by December 30, 2025. The contract falls under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $141,800.40 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price contract, which carries no set-aside designation, is a child order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,189.08 to AmerSourceBergen Drug Corp on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order is a child contract executed under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The award was made without a set-aside...
- AmerSourceBergen Drug Corp was awarded a delivery order valued at $115,054.02 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerSourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $31,536.30 delivery order to AmerSourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and medical supplies supporting federal healthcare systems. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 29, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's parent...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $4,241.60 delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively to the prime contractor's Conshohocken, Pennsylvania location. The delivery order represents a task order issued under AmerSourceBergen's larger...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCF74Delivery Order
The Department of Defense Medical Supply Chain awarded a delivery order valued at $160,252.80 to AmerSourceBergen Drug Corp (CAGE 0U9U0) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was awarded on a non-set-aside, competitive basis to support federal medical procurement needs. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. AmerSourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems, with performance of work occurring at the company's Conshohocken facility. AmerSourceBergen's federal contract portfolio demonstrates significant capability in delivering comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's competitively awarded contracts with the DLA reflect its established position as a pharmaceutical prime vendor supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems on a global basis. This delivery order aligns with the Department of Defense's strategy to leverage prime vendor agreements for efficient, flexible medical supply fulfillment across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $160.3k | 1/6/26 |